05/06/2026
New APC paper on TL1A in IBD research.
A new systematic review in ๐๐จ๐ฎ๐ซ๐ง๐๐ฅ ๐จ๐ ๐๐ซ๐จ๐ก๐งโ๐ฌ ๐๐ง๐ ๐๐จ๐ฅ๐ข๐ญ๐ข๐ฌ looks at TL1A and DR3 signalling in inflammatory bowel disease.
The review brings together 63 studies on this pathway, including work on inflammation, fibrosis and gut barrier function.
It gives researchers a clear summary of a fast-moving area and helps show where the evidence is strongest, and where more clarity is still needed.
Congratulations to Raymond Fueng-Hin Liang, Cecilia Lina Pugliano, Robert Hughes, Snehali Majumder, Antonio Lo Bello, Marietta Iacucci and Subrata Ghosh.
๐ฐ Read the paper: https://www.ovid.com/journals/jcac/fulltext/10.1093/ecco-jcc/jjag039~tl1a-as-a-therapeutic-renaissance-in-inflammatory-bowel